E1Z11: A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Aims: The purpose of this study is to find out what effects, good an/or bad , that anastrozole has on patients and whether the genes and blood can help explain how the study drug, anastrozole affects the body. Specifically, many women who take anastrozole or one of the other aromatase inbibitors (letrozole or exemestane) during treatment for breast cancer report muscle and joint aches, however, the reason that lead to these symptoms are not known. These symptoms have been designated aramoatase inhibitor-associated musculoskeletal symptom.
Diagnosis: Breast Cancer
Principal Investigator: Douglas Merkel, MD
IRB Approval Number: EH13-444
Sponsor: ECOG
Contact: Interested patients should contact research coordinator Nancy Haefling at 847.657.5957
Open to Enrollment: Yes

Home -Based Symptom management via Reflexology for Breast Cancer Patients
Aims:
The purpose of this research is to learn if a complementary therapy, called Reflexology (a specialized foot massage), provided by a friend or family member will help patients feel better physically and/or emotionally during cancer therapy. The study has the potential of leading to an enhanced system of care for breast cancer through the integration of conventional scientifically-based complementary therapies. It also focuses on advanced disease that is currently under investigation in terms of supportive care services.
Diagnosis: Breast Cancer
Principal Investigator: Elaine Wade, MD
IRB Approval Number: EH14-025
Sponsor: Michigan State University and National Cancer Institute
Contact: Interested patients should contact research coordinator Nancy Haefling at 847.657.5957
Open to Enrollment: Yes

NCI 9671: Exceptional Responders Pilot Study: Molecular Profiling of Tumors from Cancer Patients Who Are Exceptional Responders
Aims:
The purpose of this project is to investigate why particular cancer patients responded to treatment that didn’t workfor most other patients with the same disease. This knowledge may lead to better ways to prevent, detect, and treatcancer and, perhaps, other diseases as well.
Diagnosis: Cancer
Principal Investigator: Gustavo Rodriguez, M.D.
IRB Approval Number: EH15-214
Sponsor: National Cancer Institute (NCI)
Contact: Interested patients should contact research coordinator Michele Britto, RN at 847.570.2109
Open to Enrollment: Yes

 

× Alternate Text